Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sarcopenia, a condition shared by various diseases: can we alleviate or delay the progression?
Giovanni Tarantino, Gaia Sinatti, Vincenzo Citro, et al.
Internal and Emergency Medicine (2023) Vol. 18, Iss. 7, pp. 1887-1895
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Orally Deliverable Sequence-Targeted Fucoxanthin-Loaded Biomimetic Extracellular Vesicles for Alleviation of Nonalcoholic Fatty Liver Disease
Caiyun Wu, Siyuan Xiang, Haitao Wang, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 8, pp. 9854-9867
Closed Access | Times Cited: 13
Could Adverse Effects of Antibiotics Due to Their Use/Misuse Be Linked to Some Mechanisms Related to Nonalcoholic Fatty Liver Disease?
Giovanni Tarantino, Vincenzo Citro
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 1993-1993
Open Access | Times Cited: 9
The effect of gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review and network meta-analysis
Yijia Song, Sutong Liu, Lihui Zhang, et al.
Frontiers in Nutrition (2025) Vol. 11
Open Access | Times Cited: 1
Triterpenoids from Chios Mastiha Resin Against MASLD—A Molecular Docking Survey
Nаtаsа Мilоsеvic, Maja Milanović, Milica Medic‐Stojanoska, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 1, pp. 51-51
Open Access | Times Cited: 1
Association Between Remnant Cholesterol and Risk of Hyperuricemia: A Cross-Sectional Study
Zhaoxiang Wang, Menghuan Wu, Han Yan, et al.
Hormone and Metabolic Research (2024)
Closed Access | Times Cited: 6
From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients
Furong Huang, Bo Lyu, Fanci Xie, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 6
Bioprotective Role of Phytocompounds Against the Pathogenesis of Non-alcoholic Fatty Liver Disease to Non-alcoholic Steatohepatitis: Unravelling Underlying Molecular Mechanisms
Tanmoy Banerjee, Arnab Sarkar, Sk Zeeshan Ali, et al.
Planta Medica (2024) Vol. 90, Iss. 09, pp. 675-707
Open Access | Times Cited: 5
Relevant Aspects of Combined Protocols for Prevention of N(M)AFLD and Other Non‐Communicable Diseases
Luis A. Videla, Rodrigo Valenzuela, Jessica Zúñiga‐Hernández, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 7
Closed Access | Times Cited: 5
Perilipins: A family of five fat‐droplet storing proteins that play a significant role in fat homeostasis
Preethi Chandrasekaran, Sabine Weiskirchen, Ralf Weiskirchen
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 6
Open Access | Times Cited: 5
Age difference in the connection between systemic inflammatory response and metabolic syndrome
Haishan Wei, Dan Xu, Jiying Chen, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 5
GLP-1 receptor agonists in the treatment of diabetic non–alcoholic steatohepatitis patients
Ernest Adeghate
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 3, pp. 223-232
Open Access | Times Cited: 4
Association of systemic inflammatory indices with anthropometric measures, metabolic factors, and liver function in non-alcoholic fatty liver disease
Sara Arefhosseini, Taha Aghajani, Helda Tutunchi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
A novel peptide encoded by circ‐SLC9A6 promotes lipid dyshomeostasis through the regulation of H4K16ac‐mediated CD36 transcription in NAFLD
Yue Wang, Xinyao Tian, Zhecheng Wang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 4
Elevated GGT to HDL ratio as a marker for the risk of NAFLD and liver fibrosis
Yanyan Xuan, Fang-Fang He, Qing Liu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective
Swasthika Gurjar, R. A., Raghavendra Upadhya, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Ginsenoside, a potential natural product against liver diseases: a comprehensive review from molecular mechanisms to application
Sitong Shang, Haixia Yang, Linlin Qu, et al.
Critical Reviews in Food Science and Nutrition (2025), pp. 1-25
Closed Access
Association of exposure to multiple volatile organic compounds with ultrasound-defined hepatic steatosis and fibrosis in the adult US population: NHANES 2017–2020
Wentao Shao, Pan Gong, Qihan Wang, et al.
Frontiers in Public Health (2025) Vol. 12
Open Access
Aqueous extract of Atractylodes macrocephala Koidz. improves dexamethasone-induced skeletal muscle atrophy in mice by enhancing mitochondrial biological function
Mingzhu Ye, Lai Peng, Yajing Fang, et al.
Experimental Gerontology (2025) Vol. 201, pp. 112693-112693
Open Access
The systemic Immune Inflammation index is a reliable and novel risk factor for metabolic dysfunction-associated fatty liver disease
Mehmet Ali Kösekli, Gülali Aktaş
Current Medical Research and Opinion (2025), pp. 1-8
Closed Access
Respiratory sarcopenia: A scoping review of the current literature
Raju Vaishya, Anoop Misra, Mahmoud Nassar, et al.
International Journal of Diabetes in Developing Countries (2025)
Closed Access
Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease
Xiangyong Hao, Hao Song, Xin Su, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment
S L Pu, Binbin Zhao, Yuxuan Jiang, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Polysaccharides Extracted from Old Stalks of Asparagus officinalis L. Improve Nonalcoholic Fatty Liver by Increasing the Gut Butyric Acid Content and Improving Gut Barrier Function
Wenlong Sun, Jinghan Jia, Guangpeng Liu, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Clinical and pathological characteristics of metabolic dysfunction-associated steatotic liver disease and the key role of epigenetic regulation: implications for molecular mechanism and treatment
Yijing Li, Lijie Li, Yishuo Zhang, et al.
Therapeutic Advances in Endocrinology and Metabolism (2025) Vol. 16
Open Access
Resmetirom: the first approved therapy for treating metabolic dysfunction associated steatohepatitis
Sheena Bhushan, Aalam Sohal, Mazen Noureddin, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Page 1 - Next Page

Scroll to top